Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
Authors: Marie E. Faughnan, Johannes J. Mager, Steven W. Hetts, Valerie A. Palda, Felix Ratjen
Journal: Annals of Internal Medicine (2021)

LettersJuly 2021Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaMarie E. Faughnan, MD, MSc, Johannes J. Mager, MD, PhD, Steven W. Hetts, MD, Valerie A. Palda, MD, MSc, Felix Ratjen, MDMarie E. Faughnan, MD, MScSt. Michael's Hospital, Li Ka Shing Knowledge Institute, and University of Toronto, Toronto, Ontario, Canada, Johannes J. Mager, MD, PhDSt. Antonius Hospital, Nieuwegein, the Netherlands, Steven W. Hetts, MDUniversity of California, San Francisco, San Francisco, California, Valerie A. Palda, MD, MScUniversity of Toronto, Toronto, Ontario, Canada, Felix Ratjen, MDThe Hospital for Sick Children and University of Toronto, Toronto, Ontario, CanadaAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L21-0067 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE: As leaders of the International HHT Guidelines process, we appreciate the opportunity to respond to the comment from our colleague Prof. Dr. med. Geisthoff on 2 screening recommendations from the Second International HHT Guidelines. We will attempt to clarify our process in generating these recommendations and will respond in detail about the screening recommendation for pediatric brain VM.During the International HHT Guidelines process, a minimum of 80% of voting participants had to agree with a recommendation for it to move forward. For both statements that Prof. Dr. med. Geisthoff objects to, the group had an 86% or ...Reference1. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401-6. [PMID: 21208779] doi:10.1016/j.jclinepi.2010.07.015 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: St. Michael's Hospital, Li Ka Shing Knowledge Institute, and University of Toronto, Toronto, Ontario, CanadaSt. Antonius Hospital, Nieuwegein, the NetherlandsUniversity of California, San Francisco, San Francisco, CaliforniaUniversity of Toronto, Toronto, Ontario, CanadaThe Hospital for Sick Children and University of Toronto, Toronto, Ontario, CanadaDisclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-1443. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoSecond International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Marie E. Faughnan , Johannes J. Mager , Steven W. Hetts , Valerie A. Palda , Kelly Lang-Robertson , Elisabetta Buscarini , Erik Deslandres , Raj S. Kasthuri , Andrea Lausman , David Poetker , Felix Ratjen , Mark S. Chesnutt , Marianne Clancy , Kevin J. Whitehead , Hanny Al-Samkari , Murali Chakinala , Miles Conrad , Daniel Cortes , Claudia Crocione , Jama Darling , Els de Gussem , Carol Derksen , Sophie Dupuis-Girod , Patrick Foy , Urban Geisthoff , James R. Gossage , Adrienne Hammill , Ketil Heimdal , Katharine Henderson , Vivek N. Iyer , Anette D. Kjeldsen , Masaki Komiyama , Kevin Korenblatt , Jamie McDonald , Jack McMahon , Justin McWilliams , Mary E. Meek , Meir Mei-Zahav , Scott Olitsky , Sara Palmer , Rose Pantalone , Jay F. Piccirillo , Beth Plahn , Mary E.M. Porteous , Marco C. Post , Ivan Radovanovic , Paul J. Rochon , Josanna Rodriguez-Lopez , Carlo Sabba , Marcelo Serra , Claire Shovlin , Dennis Sprecher , Andrew J. White , Ingrid Winship , and Roberto Zarrabeitia Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Marianne S. Clancy , Sara Palmer , Scott Olitsky , Claudia Crocioni , and Beth Plahn Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Urban Geisthoff Metrics Cited bySafety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasiaA Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2 July 2021Volume 174, Issue 7Page: 1035-1036KeywordsAnemiaBrainCase seriesChildrenComputed axial tomographyHemoglobinHemorrhageIron deficiency anemiaLiverPregnancy ePublished: 20 July 2021 Issue Published: July 2021 Copyright & PermissionsCopyright © 2021 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...